Vernon Margaret K, Swett Laura L, Speck Rebecca M, Munera Catherine, Spencer Robert H, Wen Warren, Menzaghi Frédérique
, Evidera, Bethesda, MD, USA.
Cara Therapeutics, Inc., 4 Stamford Plaza, 107 Elm Street, 9th Fl., Stamford, CT, 06902, USA.
J Patient Rep Outcomes. 2021 Dec 24;5(1):134. doi: 10.1186/s41687-021-00404-z.
Chronic kidney disease-associated pruritus (CKD-aP) is characterized by persistent itch that often leads to substantially impaired quality of life. The Worst Itching Intensity Numerical Rating Scale (WI-NRS) is a single-item patient-reported outcome measure in which patients indicate the intensity of the worst itching they experienced over the past 24 h. Here, we evaluated the content validity and psychometric properties of the WI-NRS and confirmed the threshold of meaningful change in hemodialysis patients with moderate-to-severe CKD-aP.
Content validity interviews were conducted in 23 patients. Psychometric properties of the WI-NRS were assessed using data from one phase 2 (N = 174) and two phase 3 (N = 848) clinical trials investigating an anti-pruritic treatment. Anchor-based methods were used to confirm meaningful within-patient change score thresholds in the phase 3 trial patients and mixed-method exit interviews (N = 70) contributed further insight.
Content validity interviews indicated patients considered the WI-NRS to be straightforward, comprehensive, and relevant. Test-retest reliability was strong in both trial cohorts (intraclass correlation coefficients > 0.75). Construct validity analyses indicated high correlation between the WI-NRS and other measures of itch. Anchor-based analyses showed a reduction of ≥ 3 points from baseline score represented an appropriate clinically meaningful within-patient change on the WI-NRS. In the exit interviews, all patients with a reduction ≥ 3 points considered the change meaningful.
The WI-NRS is a reliable, valid, and responsive measure of itch intensity for patients with moderate-to-severe CKD-aP. These results support its use to assess treatment efficacy and in clinical evaluation and management of pruritus in hemodialysis patients.
慢性肾脏病相关性瘙痒(CKD-aP)的特征是持续性瘙痒,常导致生活质量严重受损。最严重瘙痒强度数字评定量表(WI-NRS)是一项由患者报告的单项结局指标,患者需指出过去24小时内经历的最严重瘙痒的强度。在此,我们评估了WI-NRS的内容效度和心理测量特性,并确定了中重度CKD-aP血液透析患者中有意义变化的阈值。
对23例患者进行了内容效度访谈。使用来自一项2期(N = 174)和两项3期(N = 848)抗瘙痒治疗临床试验的数据评估WI-NRS的心理测量特性。在3期试验患者中采用基于锚定的方法确定有意义的患者内变化评分阈值,混合方法退出访谈(N = 70)提供了进一步的见解。
内容效度访谈表明患者认为WI-NRS简单明了、全面且相关。两个试验队列的重测信度都很强(组内相关系数>0.75)。结构效度分析表明WI-NRS与其他瘙痒测量指标高度相关。基于锚定的分析显示,与基线评分相比降低≥3分代表WI-NRS上患者内有意义的临床相关变化。在退出访谈中,所有降低≥3分的患者都认为这种变化有意义。
WI-NRS是评估中重度CKD-aP患者瘙痒强度的可靠、有效且敏感的指标。这些结果支持其用于评估治疗效果以及血液透析患者瘙痒的临床评估和管理。